ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
-13.92%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$99M
AUM Growth
+$99M
Cap. Flow
+$3.23M
Cap. Flow %
3.26%
Top 10 Hldgs %
93.12%
Holding
15
New
3
Increased
6
Reduced
4
Closed
1

Top Buys

1
ARWR icon
Arrowhead Research
ARWR
$13.2M
2
QURE icon
uniQure
QURE
$11.8M
3
ARGX icon
argenx
ARGX
$4.4M
4
MRUS icon
Merus
MRUS
$2.59M
5
SYBX icon
Synlogic
SYBX
$2.36M

Top Sells

1
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$15.5M
2
LOXO
Loxo Oncology, Inc
LOXO
$11.8M
3
FATE icon
Fate Therapeutics
FATE
$3.69M
4
CTMX icon
CytomX Therapeutics
CTMX
$2.27M
5
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
$2.03M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRUS icon
1
Merus
MRUS
$4.98B
$20.7M 10.03%
1,480,855
+185,142
+14% +$2.59M
ARWR icon
2
Arrowhead Research
ARWR
$3.05B
$13.2M 6.4%
+1,064,928
New +$13.2M
QURE icon
3
uniQure
QURE
$896M
$11.8M 5.7%
+408,729
New +$11.8M
SYBX icon
4
Synlogic
SYBX
$17M
$9.35M 4.53%
1,334,179
+336,145
+34% +$2.36M
FATE icon
5
Fate Therapeutics
FATE
$120M
$8.94M 4.33%
697,096
-287,500
-29% -$3.69M
CTMX icon
6
CytomX Therapeutics
CTMX
$336M
$7.92M 3.84%
524,763
-150,000
-22% -$2.27M
SPRO icon
7
Spero Therapeutics
SPRO
$116M
$6.35M 3.07%
1,031,947
+232,256
+29% +$1.43M
XENE icon
8
Xenon Pharmaceuticals
XENE
$2.98B
$6M 2.91%
951,527
+358,725
+61% +$2.26M
ARGX icon
9
argenx
ARGX
$43.6B
$4.4M 2.13%
+45,806
New +$4.4M
LOXO
10
DELISTED
Loxo Oncology, Inc
LOXO
$3.47M 1.68%
24,750
-84,562
-77% -$11.8M
GLPG icon
11
Galapagos
GLPG
$2.07B
$3.3M 1.59%
35,920
+4,600
+15% +$422K
PVLA
12
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$3.22M 1.56%
1,210,837
-764,261
-39% -$2.03M
MOR
13
DELISTED
MorphoSys AG American Depositary Shares
MOR
$298K 0.14%
11,787
+2,700
+30% +$68.3K
XBI icon
14
SPDR S&P Biotech ETF
XBI
$5.07B
– –
0
– –
KDNY
15
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-2,105,282
Closed -$15.5M